Huan LJ - Search Results

1

The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF.

Eckford PDW, McCormack J, Munsie L, He G, Stanojevic S, Pereira SL, Ho K, Avolio J, Bartlett C, Yang JY, Wong AP, Wellhauser L, Huan LJ, Jiang JX, Ouyang H, Du K, Klingel M, Kyriakopoulou L, Gonska T, Moraes TJ, Strug LJ, Rossant J, Ratjen F, Bear CE. Eckford PDW, et al. Among authors: huan lj. J Cyst Fibros. 2019 Jan;18(1):35-43. doi: 10.1016/j.jcf.2018.03.013. Epub 2018 Oct 10. J Cyst Fibros. 2019. PMID: 29685812 Free article. Review.

2

A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR).

Ramjeesingh M, Li C, Garami E, Huan LJ, Hewryk M, Wang Y, Galley K, Bear CE. Ramjeesingh M, et al. Among authors: huan lj. Biochem J. 1997 Oct 1;327 ( Pt 1)(Pt 1):17-21. doi: 10.1042/bj3270017. Biochem J. 1997. PMID: 9355728 Free PMC article.

3

Lung disease in mice with cystic fibrosis.

Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, O'Brodovich H, Tsui LC, Buchwald M, Tanswell AK. Kent G, et al. Among authors: huan lj. J Clin Invest. 1997 Dec 15;100(12):3060-9. doi: 10.1172/JCI119861. J Clin Invest. 1997. PMID: 9399953 Free PMC article.

4

Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF mice.

Ramjeesingh M, Huan LJ, Wilschanski M, Durie P, Li C, Gyomorey K, Wang Y, Kent G, Tanswell KA, Cutz E, Ackerley C, Bear CE. Ramjeesingh M, et al. Among authors: huan lj. Hum Gene Ther. 1998 Mar 1;9(4):521-8. doi: 10.1089/hum.1998.9.4-521. Hum Gene Ther. 1998. PMID: 9525313

5

A conserved region of the R domain of cystic fibrosis transmembrane conductance regulator is important in processing and function.

Pasyk EA, Morin XK, Zeman P, Garami E, Galley K, Huan LJ, Wang Y, Bear CE. Pasyk EA, et al. Among authors: huan lj. J Biol Chem. 1998 Nov 27;273(48):31759-64. doi: 10.1074/jbc.273.48.31759. J Biol Chem. 1998. PMID: 9822639 Free article.

6

Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).

Ramjeesingh M, Li C, Garami E, Huan LJ, Galley K, Wang Y, Bear CE. Ramjeesingh M, et al. Among authors: huan lj. Biochemistry. 1999 Feb 2;38(5):1463-8. doi: 10.1021/bi982243y. Biochemistry. 1999. PMID: 9931011

7

Novel method for evaluation of the oligomeric structure of membrane proteins.

Ramjeesingh M, Huan LJ, Garami E, Bear CE. Ramjeesingh M, et al. Among authors: huan lj. Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):119-23. Biochem J. 1999. PMID: 10432308 Free PMC article.

8

Quaternary structure of the chloride channel ClC-2.

Ramjeesingh M, Li C, Huan LJ, Garami E, Wang Y, Bear CE. Ramjeesingh M, et al. Among authors: huan lj. Biochemistry. 2000 Nov 14;39(45):13838-47. doi: 10.1021/bi001282i. Biochemistry. 2000. PMID: 11076524

9

Perturbation of the pore of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibits its atpase activity.

Kogan I, Ramjeesingh M, Huan LJ, Wang Y, Bear CE. Kogan I, et al. Among authors: huan lj. J Biol Chem. 2001 Apr 13;276(15):11575-81. doi: 10.1074/jbc.M010403200. Epub 2000 Dec 21. J Biol Chem. 2001. PMID: 11124965 Free article.

10

A monomer is the minimum functional unit required for channel and ATPase activity of the cystic fibrosis transmembrane conductance regulator.

Ramjeesingh M, Li C, Kogan I, Wang Y, Huan LJ, Bear CE. Ramjeesingh M, et al. Among authors: huan lj. Biochemistry. 2001 Sep 4;40(35):10700-6. doi: 10.1021/bi0108195. Biochemistry. 2001. PMID: 11524016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page